<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: aranesp</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study shows anemia drug does not improve health of anemic heart failure patients</title>
   	 <description>Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients –darbepoetin alfa – does not improve patients' health, nor does it reduce their risk of death from heart failure.</description>
     <link>http://medicalxpress.com/news/2013-03-anemia-drug-health-anemic-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 11 Mar 2013 04:38:37 EST</pubDate>
	 <guid isPermaLink="false">news282195509</guid>
	 
</item>
<item>
     <title>Top US court allows Amgen class action suit</title>
   	 <description>The US Supreme Court ruled Wednesday in favor of investors seeking to join a class-action lawsuit against pharmaceutical giant Amgen for downplaying safety concerns about two anemia drugs.</description>
     <link>http://medicalxpress.com/news/2013-02-court-amgen-class-action.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 28 Feb 2013 05:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281248021</guid>
	 
</item>
<item>
     <title>Amgen 4Q profit drops 16 pct. on higher spending</title>
   	 <description>Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results fell short of Wall Street expectations.</description>
     <link>http://medicalxpress.com/news/2013-01-amgen-4q-profit-pct-higher.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 23 Jan 2013 17:36:36 EST</pubDate>
	 <guid isPermaLink="false">news278184989</guid>
	 
</item>
<item>
     <title>Amgen to pay record $762 mn fine over anemia drug (Update)</title>
   	 <description>US pharmaceutical giant Amgen has pleaded guilty to illegally introducing a mislabeled drug for treating anemia onto the market and will pay a record $762 million fine, officials said Wednesday.</description>
     <link>http://medicalxpress.com/news/2012-12-amgen-762m-settlement-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 18 Dec 2012 13:36:39 EST</pubDate>
	 <guid isPermaLink="false">news275060193</guid>
	 
</item>
<item>
     <title>New drug labels for kidney disease patients -- what do they mean?</title>
   	 <description>The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).</description>
     <link>http://medicalxpress.com/news/2012-01-drug-kidney-disease-patients-.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 19 Jan 2012 17:29:43 EST</pubDate>
	 <guid isPermaLink="false">news246216572</guid>
	 
</item>


</channel>
</rss>
